Clinical Trial Update: Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating adipose mesenchymal stem cells for ulcerative colitis; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Adipose Mesenchymal Stem Cells (adipose mesenchymal stem cells)

Snippet

Sponsor: Liaocheng People's Hospital | Conditions: Ulcerative Colitis (UC) | Phase 1, Phase 2 | Status: UNKNOWN